Regenesis

Cartilage Regeneration through Electrical Stimulations

Health Tech & Life Sciences
Active
Pre-Funding Qatsrin Founded 2023
Total raised
Stage
Pre-Funding
Founded
2023
Headcount
1
HQ
Qatsrin
Sector
Health Tech & Life Sciences

About

Regenesis is a biomedical startup aims to revolutionize treatment of cartilage lesions by in situ enhancement of cartilage regeneration. Our innovative solution enables full restoration of the cartilage through a minimally invasive procedure.

Regenesis platform is based on a unique biocompatible structure designed to be applied directly or indirectly to the damaged area. The platform can be adopted for tissue regeneration of various medical conditions associated with cartilage damage.

The platform can be adopted for tissue regeneration of various medical conditions. The company's portfolio includes include the treatment of hip and ankle lesions and treatment of Osteoarthritis (OA)

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Regenesis' primary focus in the biomedical field?
Regenesis is a biomedical startup focused on revolutionizing the treatment of cartilage lesions by enhancing in situ cartilage regeneration through a minimally invasive procedure.
When was Regenesis founded?
Regenesis was founded in February 2023.
Where is Regenesis headquartered?
Regenesis is headquartered in Qatsrin, North District, Israel, specifically in the Industrial Area.
What is the core technology behind Regenesis' platform?
Regenesis' platform is based on a unique biocompatible structure designed for direct or indirect application to damaged areas, enabling tissue regeneration through electrical stimulations.
What medical conditions does Regenesis' platform aim to treat?
Regenesis' platform can be adopted for tissue regeneration in various medical conditions, including hip and ankle lesions and the treatment of Osteoarthritis (OA).
What is Regenesis' current funding stage?
Regenesis is currently in the Pre-Funding stage.
How many employees does Regenesis currently have?
Regenesis currently has 1-10 employees.
Does Regenesis hold any patents?
Yes, Regenesis holds 1 patent.
What is the primary sector classification for Regenesis?
Regenesis' primary sector classification is Health Tech & Life Sciences.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

regenerative-medicinemedical-devicesbioconvergenceminimally-invasivetissue-regenerationosteoarthritis